Koninklijke Philips N.V. (NYSE:PHG) shares fell after the U.S. FDA issued a warning letter citing multiple compliance ...
The warning follows inspections of three Philips facilities that found failures to meet standards for reporting complaints ...
The U.S. Food and Drug Administration has issued a safety communication saying certain HeartStart automated external defibrillator devices made by Philips Medical Systems, a division of Philips ...
It is an advanced defibrillator equipped with groundbreaking Real CPR Help technology. This innovative device guides rescuers in administering high-quality CPR and stands ready to deliver a ...
In a letter to Philips’ CEO, the FDA cited quality system issues at three of Philips’ manufacturing sites, and failures over complaints handling.
The U.S. Food and Drug Administration has flagged three of Philips' medical device facilities after inspections found they ...
The letter, dated Sept. 9, was issued by the Center for Devices and Radiological Health. It follows inspections of Philips Ultrasound facilities in Bothell, Wash. and Reedsville, Pa., as well as a ...
Philips HeartStart OnSite AEDs help allow anyone with little or no training to treat the most common cause of suspected sudden cardiac arrest (SCA) by delivering a shock quickly and effectively, ...